Results
237
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
237 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SRPT | US$124.65 | -3.3% | 5.3% | US$11.9b | US$194.36 | PE251.3x | E44.1% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$147.40 | 7.2% | 40.2% | US$29.4b | US$150.23 | PE77.8x | E32.9% | 2.5% | Diversified Financials | ||
NVDA | US$119.10 | 15.8% | 171.3% | US$2.9t | US$149.62 | PE55.1x | E22.2% | 0.03% | Semiconductors | ||
NU | US$14.74 | 7.6% | 100.3% | US$70.6b | US$14.70 | PB10.2x | E27.3% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
KSPI | US$123.95 | 0.5% | n/a | US$23.6b | US$152.54 | PE12.1x | E22.5% | 5.7% | Diversified Financials | ||
SMCI | US$457.16 | 18.3% | 83.4% | US$26.8b | US$823.46 | PE22.2x | E27.1% | n/a | Tech | ||
CG | US$40.05 | 7.6% | 19.4% | US$14.3b | US$47.25 | PS5.1x | E22.0% | 3.5% | Diversified Financials | ||
OWL | US$17.54 | 8.9% | 36.1% | US$25.7b | US$20.15 | PE106.7x | E89.8% | 4.1% | Diversified Financials | ||
DASH | US$131.35 | 6.3% | 62.3% | US$54.1b | US$143.46 | PS5.6x | E58.3% | n/a | Consumer Services | ||
RYAN | US$64.08 | 0.7% | 30.5% | US$16.8b | US$66.89 | PE98.3x | E61.1% | 0.7% | Insurance | ||
SN | US$103.24 | 9.0% | 153.6% | US$14.4b | US$103.42 | PE58.8x | E24.3% | n/a | Consumer Durables | ||
PTC | US$172.23 | 4.5% | 21.8% | US$20.7b | US$198.66 | PE70x | E23.9% | n/a | Software | ||
ONON | US$48.63 | 9.4% | 62.4% | US$15.6b | US$47.00 | PE85.7x | E24.3% | n/a | Consumer Durables | ||
NTNX | US$59.06 | -1.7% | 66.9% | US$14.6b | US$73.32 | PS6.8x | E88.9% | n/a | Software | ||
VRT | US$85.76 | 19.5% | 124.7% | US$32.2b | US$101.55 | PE64.5x | E29.7% | 0.1% | Capital Goods | ||
ALNY | US$265.27 | 7.5% | 43.4% | US$34.1b | US$283.17 | PS14.5x | E65.2% | n/a | Pharmaceuticals & Biotech | ||
SPOT | US$337.90 | 4.7% | 113.1% | US$67.9b | US$389.74 | PE131.4x | E29.9% | n/a | Media | ||
TER | US$131.23 | 8.1% | 37.4% | US$21.4b | US$143.95 | PE43.2x | E22.7% | 0.4% | Semiconductors | ||
ZS | US$170.06 | 8.5% | 8.9% | US$25.9b | US$214.59 | PS12x | E40.8% | n/a | Software | ||
ARM | US$147.37 | 25.6% | 142.6% | US$154.4b | US$135.76 | PE364.3x | E32.3% | n/a | Semiconductors | ||
MPWR | US$914.10 | 13.4% | 96.9% | US$44.6b | US$945.27 | PE108.4x | E23.4% | 0.5% | Semiconductors | ||
MRVL | US$74.48 | 12.5% | 36.7% | US$64.5b | US$91.60 | PS12.2x | E63.5% | 0.3% | Semiconductors | ||
HUBS | US$491.17 | -1.1% | -4.0% | US$25.2b | US$614.72 | PS10.5x | E46.1% | n/a | Software |